INSIGHTS FROM THE MOLECULAR DOCKING ANALYSIS OF COLISTIN WITH THE PMRA PROTEIN MODEL FROM ACINETOBACTER BAUMANNII

Abstract

Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 µg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.